Delta Technology Holdings Limited (NASDAQ:DELT)
Delta Technology Holdings Limited (NASDAQ:DELT) represented a move of 0 percent or $0.02 per share and closed its previous day trading session at $0.98. 0 Shares were traded in the last trading session with an Average Volume of 73.46 Million Shares. The stock currently has a Market Capitalization of 11.96 Million.
The stock traded between $0.680 and $4.700 over 1-Year time period showing its price to sales ratio of 0.31. Delta Technology Holdings Limited (NASDAQ:DELT) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $0.91 and 200-Day Simple Moving Average of $-5.55. Its Price to Free Cash Flow is 0 and Price to Book of 0.
Analyst’s recommended the stock as 0 where 1 represents Strong Buy and 5 represents Sell.
Vaxart, Inc. (NASDAQ:VXRT)
In the last trading session, Vaxart, Inc. (NASDAQ:VXRT) added its value by 0% closing at the price of $2.96. The stock currently has market capitalization of 20.28 Million, with average volume of 415.32 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Vaxart, Inc. (NASDAQ:VXRT) is showing beta of -0.04. This particular value of beta suggests that Vaxart, Inc. (NASDAQ:VXRT) has historically moved -4% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Vaxart, Inc. (NASDAQ:VXRT) is at $-89.
The stock currently has RSI of 46.16. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company’s vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.
Vaxart, Inc. (NASDAQ:VXRT) topped its 52-week high price of $9.46 on 02/09/18 and 52-Week Low Price of $2.37 on 09/18/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 14.40% and monthly volatility of 12.11% respectively.